Official Warns Myanmar Likely Conduit For Drug-Resistant Malaria Spread
This article was originally published in PharmAsia News
A Myanmar health official warned his nation could serve as the conduit to a Southeast Asia spread of the new drug-resistant form of malaria if the disease is allowed to cross its borders.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.